← All trials
NCT06343311
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2024
- Primary completion
- Dec 31, 2026
- Completion date
- Dec 31, 2027
- First posted
- Apr 2, 2024
- Last posted
- Aug 2, 2024
- Enrollment
- 21
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Estrella Biopharma, Inc.Lead sponsor
- Aeon Therapeutics (Shanghai) Co., Ltd.Official
- Aeon Therapeutics (Shanghai) Co., Ltd.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.